WO2007143131A3 - Prednisolone sodium phosphate formulations - Google Patents

Prednisolone sodium phosphate formulations Download PDF

Info

Publication number
WO2007143131A3
WO2007143131A3 PCT/US2007/013008 US2007013008W WO2007143131A3 WO 2007143131 A3 WO2007143131 A3 WO 2007143131A3 US 2007013008 W US2007013008 W US 2007013008W WO 2007143131 A3 WO2007143131 A3 WO 2007143131A3
Authority
WO
WIPO (PCT)
Prior art keywords
tablets
sodium phosphate
prednisolone sodium
phosphate formulations
odts
Prior art date
Application number
PCT/US2007/013008
Other languages
French (fr)
Other versions
WO2007143131A9 (en
WO2007143131A2 (en
Inventor
Walid Habib
Bhaveshkumar Kothari
Original Assignee
Cima Labs Inc
Walid Habib
Bhaveshkumar Kothari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/638,260 external-priority patent/US20070281014A1/en
Priority claimed from US11/638,216 external-priority patent/US8637076B2/en
Application filed by Cima Labs Inc, Walid Habib, Bhaveshkumar Kothari filed Critical Cima Labs Inc
Priority to MX2008015059A priority Critical patent/MX2008015059A/en
Priority to CA002653485A priority patent/CA2653485A1/en
Publication of WO2007143131A2 publication Critical patent/WO2007143131A2/en
Publication of WO2007143131A9 publication Critical patent/WO2007143131A9/en
Publication of WO2007143131A3 publication Critical patent/WO2007143131A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Abstract

The present invention relates to tablets containing prednisolone salts and in particular prednisolone sodium phosphates. The tablets include ODTs and non- ODTs, effervescent tablets and noneffervescent tablets and tablets meeting certain performance criteria.
PCT/US2007/013008 2006-06-01 2007-05-30 Prednisolone sodium phosphate formulations WO2007143131A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2008015059A MX2008015059A (en) 2006-06-01 2007-05-30 Prednisolone sodium phosphate formulations.
CA002653485A CA2653485A1 (en) 2006-06-01 2007-05-30 Prednisolone salt formulations

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US81001506P 2006-06-01 2006-06-01
US60/810,015 2006-06-01
US11/638,260 US20070281014A1 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,216 2006-12-13
US11/638,216 US8637076B2 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,260 2006-12-13

Publications (3)

Publication Number Publication Date
WO2007143131A2 WO2007143131A2 (en) 2007-12-13
WO2007143131A9 WO2007143131A9 (en) 2008-02-14
WO2007143131A3 true WO2007143131A3 (en) 2008-03-20

Family

ID=38616310

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/013008 WO2007143131A2 (en) 2006-06-01 2007-05-30 Prednisolone sodium phosphate formulations
PCT/US2007/012883 WO2007143061A2 (en) 2006-06-01 2007-05-31 Prednisolone salt formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US2007/012883 WO2007143061A2 (en) 2006-06-01 2007-05-31 Prednisolone salt formulations

Country Status (3)

Country Link
CA (2) CA2653485A1 (en)
MX (2) MX2008015059A (en)
WO (2) WO2007143131A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926722B1 (en) * 2008-01-25 2010-09-03 Substipharm Dev APPROPRIATE PHARMACEUTICAL FORMULATION FOR THE PREPARATION OF ORODISPERSIBLE PRELOISOLONE TABLETS

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (en) *
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
WO2000030617A1 (en) * 1998-11-25 2000-06-02 Cima Labs Inc. Taste masking rapid release coating system
WO2003053415A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
WO2004060354A1 (en) * 2002-12-31 2004-07-22 Augsburger Larry L Methods for making pharmaceutical dosage forms containing active cushioning components
US20050287211A1 (en) * 2004-04-30 2005-12-29 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (en) *
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
WO2000030617A1 (en) * 1998-11-25 2000-06-02 Cima Labs Inc. Taste masking rapid release coating system
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
WO2003053415A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
WO2004060354A1 (en) * 2002-12-31 2004-07-22 Augsburger Larry L Methods for making pharmaceutical dosage forms containing active cushioning components
US20050287211A1 (en) * 2004-04-30 2005-12-29 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "BioMarin Announces U.S. FDA Acceptance of Orapred ODT Filing", NEW DRUG APPLICATIONS, 19 October 2005 (2005-10-19), XP002462634, Retrieved from the Internet <URL:http://www.drugs.com/nda/orapred_odt_051019.html> [retrieved on 20071217] *
BERTHOLD A ET AL: "Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 39, no. 1, March 1996 (1996-03-01), pages 17 - 25, XP004037383, ISSN: 0168-3659 *

Also Published As

Publication number Publication date
CA2653485A1 (en) 2007-12-13
WO2007143131A9 (en) 2008-02-14
WO2007143131A2 (en) 2007-12-13
MX2008015058A (en) 2009-04-14
WO2007143061A3 (en) 2008-02-14
CA2653480A1 (en) 2007-12-13
MX2008015059A (en) 2009-04-14
WO2007143061A2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
HUP0600027A2 (en) Antiseptic compositions, methods and systems
GB0415219D0 (en) Improvements in or relating to time-of-flight ranging systems
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2008073483A3 (en) Methods and systems related to receiving nutraceutical associated information
WO2006125539A3 (en) Combination therapy comprising diaryl ureas for treating diseases
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
MX2009013338A (en) Perfume systems.
WO2005070183A3 (en) Ice cream and ice cream formulations containing maltitol
WO2007021730A3 (en) Hair hold formulations
WO2007124102A3 (en) Preparation and use of phlorizin compositions
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
EP1916251A4 (en) Erianin salts, their preparation methods and pharmaceutical compositions containing the same
WO2008142569A3 (en) Topical compositions containing magaldrate
WO2007144521A3 (en) Cosmetic composition for topical use comprising wasabi
WO2007029087A3 (en) Controlled release multiple unit formulations
WO2008073863A3 (en) Preparation and utility of substituted allylamines
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
WO2007098924A3 (en) Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof
IL190459A0 (en) Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
WO2007143131A3 (en) Prednisolone sodium phosphate formulations
EP1880727A3 (en) Topical vaginal pharmaceutical compositions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2653485

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: MX/A/2008/015059

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07795639

Country of ref document: EP

Kind code of ref document: A2